Condition: Alzheimers Disease · Sponsor: Hoffmann-La Roche
The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment \[MCI\] to mild dementia due to AD).
This description comes directly from the study's public registry record.
Reference Study ID Number: WN45443 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Banner Sun Health Research Institute | Sun City, Arizona, United States | Recruiting |
| Irvine Center for Clinical Research | Irvine, California, United States | Recruiting |
| Inglewood Clinicals | Los Angeles, California, United States | Recruiting |
| UCSF - Memory and Aging Center | San Francisco, California, United States | Recruiting |
| Syrentis Clinical Research | Santa Ana, California, United States | Recruiting |
| K2 Medical Research - The Villages | Lady Lake, Florida, United States | Recruiting |
| K2 Medical Research, LLC | Maitland, Florida, United States | Recruiting |
| Renstar Medical Research | Ocala, Florida, United States | Recruiting |
| Axiom Brain Health LLC | Tampa, Florida, United States | Recruiting |
| Charter Research - Lady Lake/The Villages | The Villages, Florida, United States | Recruiting |
| Alzheimer?s Research and Treatment Center | Wellington, Florida, United States | Recruiting |
+ 131 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07169578